BridgeMD
New treatment option for Triple Negative Breast Cancer
Official title The Role of Simvastatin in the Epithelial-Mesenchymal Transition Process of Breast Cancer
ClinicalTrials.gov ID: NCT05550415
What this study is testing
What is Simvastatin 40mg?
Simvastatin 40mg is an investigational medicine, being studied as a potential treatment for triple negative breast cancer.
Also referred to as Simvastatin.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- Introduction: Most cases of Triple Negative Breast Cancer (TNBC) have a high proliferation rate. TNBC is associated with a poor prognosis, a high recurrence rate, and a high incidence of distant metastases.
- Phase 2: a mid-size study of how well it works
- You might receive a placebo (an inactive treatment) instead of the study drug, decided by chance. You may not know which one you got.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older, women only
You may be able to join if
- Female patients with advanced breast cancer (locally advanced and distantly advanced) with triple-negative molecular type confirmed by biopsy and...
- The patient planned to receive 8 cycles of AC-T chemotherapy.
- Patient age \> 18 years.
- Willing to participate in research by signing informed consent.
You likely can't join if
- The patient is pregnant or breastfeeding.
- Patients who have received chemotherapy or are on simvastatin therapy.
- Allergy to statins.
The study team makes the final eligibility decision.
Where it's taking place
- Jakarta Pusat, DKI Jakarta, Indonesia
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling female, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Jakarta Pusat, DKI Jakarta, Indonesia. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.